American Journal of Physiology -- Legacy Content 1995-04-01

Tumor necrosis factor induces E-selectin production in splanchnic artery occlusion shock.

D Altavilla, F Squadrito, P Canale, M Ioculano, G M Campo, G Squadrito, A Saitta, A P Caputi

Index: Am. J. Physiol. 268(4 Pt 2) , H1412-7, (1995)

Full Text: HTML

Abstract

Splanchnic arteries were clamped for 45 min to induce splanchnic artery occlusion (SAO) shock in anesthetized rats. Sham-operated animals were used as controls. Survival time, serum tumor necrosis factor-alpha (TNF-alpha), white blood cell (WBC) count, mean arterial blood pressure, myeloperoxidase (MPO) activity, and serum levels of soluble E-selectin (sE-selectin) were investigated. SAO-shocked rats exhibited decreased survival time (95 +/- 11 min, whereas sham-shocked rats survived for > 5 h), reduced mean arterial blood pressure, increased serum levels of TNF-alpha (185 +/- 8 U/ml) and MPO activity in the ileum (0.11 +/- 0.03 U x 10(-3)/g tissue) and lung (1.5 +/- 0.4 U x 10(-3)/g tissue), leukopenia, and enhanced serum levels of sE-selectin. Furthermore SAO-shocked rats showed histological alterations in the ileum and lung. Administration of cloricromene (2 mg/kg i.v.), an inhibitor of TNF-alpha, significantly increased survival time (225 +/- 10 min), decreased serum levels of TNF-alpha and sE-selectin, reduced leukopenia and MPO activity in the ileum (0.035 +/- 0.003 U x 10(-3)/g tissue) and lung (0.3 +/- 0.005 U x 10(-3)/g tissue), improved the cardiovascular changes, and reduced the histological changes in the ileum and lung. Finally, an anti-E-selectin antibody protected rats against SAO shock. Our findings are consistent with an involvement of E-selectin, "in vivo," in the pathogenesis of SAO shock.


Related Compounds

Related Articles:

Cloricromene in endotoxemia: role of NF-kappaB.

2004-08-01

[Naunyn Schmiedebergs Arch. Pharmacol. 370(2) , 140-5, (2004)]

Preparation and characterization of eudragit retard nanosuspensions for the ocular delivery of cloricromene.

2006-01-01

[AAPS PharmSciTech 7(1) , E27, (2006)]

Enhancement of availability of cloricromene at brain level by a lipophilic prodrug.

2006-07-01

[J. Pharm. Pharmacol. 58(7) , 1001-5, (2006)]

Cloricromene, a coumarine derivative, reduced the development of periodontitis in rats.

2006-04-01

[Naunyn Schmiedebergs Arch. Pharmacol. 373(1) , 51-9, (2006)]

Effect of cloricromene on intermittent claudication. A randomized, double-blind, placebo-controlled trial in patients treated with aspirin: effect on claudication distance and quality of life. CRAMPS Investigator Group. Cloricromene Randomized Arteriopathy Multicenter Prospective Study.

2000-01-01

[Vasc. Med. 5(2) , 83-9, (2000)]

More Articles...